PDL BioPharma (PDLI) Posts Q1 EPS of $0.04
Get Alerts PDLI Hot Sheet
Join SI Premium – FREE
PDL BioPharma (NASDAQ: PDLI) reported Q1 GAAP EPS of $0.04, which may not compare to the analyst estimate of $0.05. Revenue for the quarter came in at $45.4 million versus the consensus estimate of $50.23 million.
For earnings history and earnings-related data on PDL BioPharma (PDLI) click here.
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share